Survival-associated meQTLs across different cancer types


We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.


e.g., "BLCA"
e.g., "rs11600543"


Cancer type
SNP ID
SNP position (hg19)
Alleles (A/a)
log-rank test p-value
Sample size
Median survival time AA
Median survival time Aa
Median survival time aa
Dispaly
PRAD rs62073275 chr17:62981233 A/G 8.32E-9 490 30.78 31.37 19.63 KM Plot
PRAD rs62073277 chr17:62984552 T/C 1.24E-8 480 30.8 31.9 19.63 KM Plot
PRAD rs62073280 chr17:62985029 C/T 1.21E-8 479 30.8 31.93 19.63 KM Plot
PRAD rs62073281 chr17:62985050 G/A 1.21E-8 479 30.8 31.93 19.63 KM Plot
PRAD rs62073282 chr17:62985059 C/T 1.21E-8 479 30.8 31.93 19.63 KM Plot
PRAD rs62073283 chr17:62985353 T/G 1.19E-8 482 30.8 31.37 19.63 KM Plot
PRAD rs62073284 chr17:62985387 T/G 1.02E-8 484 30.8 31.62 19.63 KM Plot
PRAD rs62073285 chr17:62985691 T/C 7.89E-9 489 30.8 31.37 19.63 KM Plot
PRAD rs62075725 chr17:79611510 A/G 2.33E-7 478 30.47 32.4 25.67 KM Plot
PRAD rs62080206 chr17:79635058 C/T 4.44E-5 489 30.77 31.37 25.67 KM Plot
PRAD rs62080208 chr17:79636153 C/G 6.0E-5 490 30.77 31.37 25.17 KM Plot
PRAD rs62080209 chr17:79636653 A/G 2.85E-8 482 29.63 31.62 25.67 KM Plot
PRAD rs62083913 chr18:39475624 G/T 0.000115 484 29.15 37.32 24.63 KM Plot
PRAD rs62083914 chr18:39480770 A/C 0.000137 479 29.02 36.6 24.63 KM Plot
PRAD rs62143892 chr19:54032240 A/G 7.48E-6 491 30.8 33.07 20.32 KM Plot